The scandal involving Kanebo Cosmetics’ skin-whitening products shows that the company’s business-as-usual attitude has caused suffering for a large number of consumers. Both people in the pharmaceutical, cosmetics and food industries, and experts and officials engaged in examination of the safety of related products should draw lessons from the Kanebo scandal and ask themselves whether they are doing their best to ensure that its products are safe for consumers and taking timely action to issue product recalls when necessary.
A team of lawyers appointed by Kanebo issued a report on Sept. 11 criticizing the company for dragging its feet in issuing the recall of skin-whitening products that have been blamed for leaving nearly 10,000 customers with leukoderma — a loss of skin pigmentation. The report said that the company should have taken necessary steps in September 2012 at the latest when evidence suggested that the products were causing leukoderma. It wasn’t until July that Kanebo began to recall 54 products containing 4HPB, a synthetic substance that it had developed.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.